Physician profile
Daniel Alexander Ramirez
NPI 1366088452
$1,519.64
in general payments reported to CMS, 2019-2025
10 companies · $659 in 2025
The $659 reported for 2025 was more than what 81% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $439 · 2023: $19.66 · 2024: $402 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,081.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $722.62 | 2022-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| Edwards Lifesciences Corporation | $422.61 | 2022-2025 | Konect Resilia |
| Baxter Healthcare | $142.64 | 2025 | Perclot |
| Abiomed | $98.18 | 2025 | |
| Medtronic, INC. | $39.75 | 2022-2024 | Illumisite |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.63 | 2025 | Lifevest |
| Siemens Medical Solutions USA, INC. | $20.48 | 2024 | Naeotom Alpha |
| Bard Peripheral Vascular, INC. | $19.66 | 2023 | |
| Solventum Corporation | $16.62 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, Prevena |
| Kci USA, INC. | $14.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.